UnknownNot applicableNCT06495905
Efficacy and Safety of Systematic Therapy and Bronchoscopic Interventional Treatment for Pulmonary Mucormycosis
Studying Zygomycosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Principal Investigator
- Manting Liu, MDTsinghua University
- Intervention
- transbronchoscopic interventional debridement(procedure)
- Enrollment
- 30 target
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2024 – 2025
Study locations (1)
- Beijing TsingHua ChangGung hospital, Beijing, Beijing Municipality, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06495905 on ClinicalTrials.govOther trials for Zygomycosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07339800Chest CT Scan in Pulmonary Mucormycosis: Prognostic ValueUniversity Hospital, Strasbourg, France
- ACTIVE NOT RECRUITINGNCT07191756Amphotericin B Versus Isavuconazole for Mucormycosis: A Comparative Efficacy and Safety StudyQiu Ye
- RECRUITINGNCT07185503Liposomal Amphotericin B Plus Posaconazole/Isavuconazole for Mucormycosis in Hematologic Malignancies: Efficacy and SafetyInstitute of Hematology & Blood Diseases Hospital, China
- ACTIVE NOT RECRUITINGNCT06515743Rehabilitation With an Obturator in Maxillary DefectsMenoufia University
- RECRUITINGNCT05406037Biomarkers for Invasive MucormycosisUniversity Hospital, Lille
- RECRUITINGPHASE2NCT05468372Amphotericin Versus Posaconazole for Pulmonary MucormycosisPost Graduate Institute of Medical Education and Research, Chandigarh